Equity Analyst, LightStream Research

Shifara Samsudeen, ACMA, CGMA

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Event-Driven

<ul>
<li>Tencent announced today that its board of directors has resolved to declare a special dividend by way of a distribution of its Class A ordinary shares of JD.com. </li>
<li>There is increased speculation that there is more divestments to come that including Tencent’s stakes in Meituan, Kuaishou and Pinduoduo.</li>
<li>Tencent’s shares are up 4.3% from yesterday’s close following the announcement while JD.com is 7.1% down from its previous close.</li>
</ul>


Tencent announced today that its board of directors has resolved to declare a special dividend by way of a distribution of its Class A ordinary shares of JD.com. 
There is increased speculation that there is more divestments to come that including Tencent’s stakes in Meituan, Kuaishou and Pinduoduo.
Tencent’s shares are up 4.3% from yesterday’s close following the announcement while JD.com is 7.1% down from its previous close.


Tencent’s Special Dividend: Is It a Sign the Walled Gardens Are Coming Down?

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

<ul>
<li>This morning, <a href="https://www.smartkarma.com/entities/tencent-holdings-ltd" target="_blank" data-smartkarma-citation="entities:26:1" rel="noopener">Tencent (700 HK)</a> declared an interim dividend by way of in-specie distribution of <a href="https://www.smartkarma.com/entities/jd-com-inc-adr" target="_blank" data-smartkarma-citation="entities:446:1" rel="noopener">JD.com Inc (ADR) (JD US)</a> / <a href="https://www.smartkarma.com/entities/jd-com-inc" target="_blank" data-smartkarma-citation="entities:29043:1" rel="noopener">JD.com Inc. (9618 HK)</a> shares. </li>
<li>The distribution is 457,326,671 Tencent-held (86.4% of holdings) Class A Ordinary shares of JD.com - 1 share per 21 Tencent shares held - to Qualifying Shareholders on the record...</li>
<li>...date which is 25 January 2022, with 'delivery' on or about 25 March 2022. Non-Qualifying Shareholders will get cash. The details matter.</li>
</ul>


This morning, Tencent (700 HK) declared an interim dividend by way of in-specie distribution of JD.com Inc (ADR) (JD US) / JD.com Inc. (9618 HK) shares. 
The distribution is 457,326,671 Tencent-held (86.4% of holdings) Class A Ordinary shares of JD.com - 1 share per 21 Tencent shares held - to Qualifying Shareholders on the record...
...date which is 25 January 2022, with 'delivery' on or about 25 March 2022. Non-Qualifying Shareholders will get cash. The details matter.


Tencent's Big In-Specie Dividend of JD.com Shares

Financials & FinTech research, Galliano’s Financials Research

Victor Galliano

Financials & FinTech research

Financials & FinTech, EM & Developed Markets

Galliano’s Financials Research

Galliano's Financials Research provides fundamental research in Emerging Markets financials, including FinTech, as well as financials in select Developed Markets.

The investment style applied is generally value oriented, although Growth At Reasonable Price (GARP) strategies can also be used where appropriate. 

Our investment research approach aim is often contrarian, looking to capitalise on overly sceptical or optimistic consensus views. In terms of valuation techniques, the focus is on PBV ratio to ROE, PE multiples and dividend yield, as well as the application of PEG ratios and, where appropriate, Sum of the Parts (SOTP) valuations.

Equity Bottom-Up

Alibaba Group Holding  / Equity Bottom-Up

<ul>
<li>Alibaba’s share price is very close to its four year low due to the Tech fallout and regulatory concerns about the Chinese government; nonetheless, much bad news is now discounted</li>
<li>The share price weakness also reflects investor concerns about BABA’s potential NYSE delisting, following Didi’s NYSE delisting announcement last month under pressure from the Chinese authorities</li>
<li>Alibaba is very close to a long term PEG ratio of 1x based on consensus estimates, and trades on very modest earnings and EBITDA multiples given its continued growth potential</li>
</ul>


Alibaba’s share price is very close to its four year low due to the Tech fallout and regulatory concerns about the Chinese government; nonetheless, much bad news is now discounted
The share price weakness also reflects investor concerns about BABA’s potential NYSE delisting, following Didi’s NYSE delisting announcement last month under pressure from the Chinese authorities
Alibaba is very close to a long term PEG ratio of 1x based on consensus estimates, and trades on very modest earnings and EBITDA multiples given its continued growth potential


Alibaba (BABA US): Looking to a Better ‘22

Chart based progressive global trading strategies, Chart Partners

Thomas Schroeder

Chart based progressive global trading strategies

Chart Partners

Chart Partners objective is to discover medium-term cycle turns and profit opportunities before they unfold, within structural trends while preserving capital with clear degrees of risk. We have real return ideas. 

Markets are dynamic and trading systems must reflect this. It is crucial to determine underlying correlations and lead-lag relationships within global markets and the impact on linked instruments. Our weekly Chartonics product gives you short-term trading strategies that can be applied within the medium and longer term macro trends that are mapped out in our strategy updates. 

Our methodology fuses global market variables and isolates drivers in trends. We specialize in FX, index trade in NY and Asia with a focus on Asian stocks. 

Technical Analysis

<ul>
<li>Meituan sell call at the top of the wedge near 300 and on the wedge support break is unfolding toward our downside targets at 232 (broken) and 205.</li>
<li>Buy volumes had been deteriorating on the way up and was a key input to short. Sell volumes have picked up.</li>
<li>205-200 the level to reduce/close short and where a long trade sets up. Need to tie this in with late December capitulation (global cycle).</li>
</ul>


Meituan sell call at the top of the wedge near 300 and on the wedge support break is unfolding toward our downside targets at 232 (broken) and 205.
Buy volumes had been deteriorating on the way up and was a key input to short. Sell volumes have picked up.
205-200 the level to reduce/close short and where a long trade sets up. Need to tie this in with late December capitulation (global cycle).


Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine as of record day of December 17th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight inflows into Tencent, Meituan and Tsingtao, as well as outflows from Wuxi Biologics, Xiaomi, and Great Wall Motor.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine as of record day of December 17th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight inflows into Tencent, Meituan and Tsingtao, as well as outflows from Wuxi Biologics, Xiaomi, and Great Wall Motor.


Hong Kong Connect Flows: Chinese Buying Tsingtao Brewery

China

Meituan operates as a web based shopping platform for locally found consumer products and retail services. The Company offers deals of the day by selling vouchers on local services and entertainment, dining, delivery, and other services. Meituan provides its services throughout China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Meituan (3690 HK)

Tencent’s Special Dividend: Is It a Sign the Walled Gardens Are Coming Down?

There is increased speculation that there is more divestments to come including Meituan, Kuaishou and Pinduoduo and we think the liberalisation of...

Shifara Samsudeen, ACMA, CGMA

Tencent's Big In-Specie Dividend of JD.com Shares

Tencent has decided to distribute the vast majority of the JD.com shares it holds. JD.com got sold off and Tencent got a bump. The Tencent bump is...

Travis Lundy

Alibaba (BABA US): Looking to a Better ‘22

Alibaba's big discounts on valuations to its Tech peers, and reduced short interest, indicate that regulatory concerns and the risk of NYSE...

Victor Galliano

Meituan Short to Long Reverse Support

Meituan sell call at the top of the wedge and on the wedge support break is unfolding toward our downside target at 205 where we bottom fish for a...

Thomas Schroeder

Hong Kong Connect Flows: Chinese Buying Tsingtao Brewery

We highlight Hong Kong Connect inflows into Tencent (700 HK), Meituan (3690 HK), Tsingtao Brewery (168 HK), and outflows from Wuxi Biologics (2269...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)